Funding @ 2017-02-19 21:58:11 UTC 2bc22033df046be402e5cf71509c8990a165737d6d10d1a87d34b54f893c6ddd:27
Spending @ 2017-02-20 01:29:43 UTC ee959a7ac3f51768d280a6509713ad31c5abeadfe053e8e45dcc6b4bd3401a80:4
|
Funding @ 2017-02-18 23:42:55 UTC 473b704a701ebe626c85c3c0ba306f6613e351044fd43175e6d8c6d704b86fc4:23
Spending @ 2017-02-19 01:58:00 UTC 3b9e90b1e8c188b8f8ae039ad71917da2cdb535bf6aa6ee994b1192f453ce82b:7
|
Funding @ 2017-02-17 18:46:36 UTC c2f4c3b00042125b3facc23f325130968a0628cbcdfcb2c4d2d4d2632a2dcd54:5
Spending @ 2017-02-17 23:27:51 UTC 0e80079e7ef9f70346c5d03759dcbc3d87a3847c66443d7880da77f7777f47a2:1
|
Funding @ 2017-02-16 20:49:46 UTC 3037d254104786ff4a9ee4ef798d3fc074d535eebe734cb21eee8ee57723fa39:20
Spending @ 2017-02-16 21:32:56 UTC 8952f9769bafd2967e998f98bef925ba8e0eb412e874f414957cbe2c886984bc:0
|
Funding @ 2017-02-15 20:27:26 UTC c9919b9072ec205eba21bed9596c9dfe756c73c6dc95678eef3d911516eec3bc:15
Spending @ 2017-02-16 01:31:02 UTC 9adabe284ef274cb6f0f01a35f7ee7cdda65dcc8ac911b9f8a6f97b2068f452d:0
|
Funding @ 2017-02-14 20:18:22 UTC 70a73c1f9cd4293948b3d98d6296566606ebc65ca05830f2da35d98cff1e2587:2
Spending @ 2017-02-15 02:03:34 UTC 062628d53da11f0b517d79706af7d877b87712207f68599d878edcd752fcd676:4
|
Funding @ 2017-02-14 18:06:39 UTC 738f0abfc29df589774d6f387c8eb97536c8cf891f348ef823669c6ddb9e0f2c:15
Spending @ 2017-02-14 21:34:55 UTC 34652bc44718d248cd2e66e95e58bf5d08f04f6d19bc292632ddbce214483040:9
|
Funding @ 2017-02-12 17:53:32 UTC b89e540c372eaa883e7fef1a3e5d223c836bf8f8988c4b81a0051a9dc7341b83:1
Spending @ 2017-02-12 23:07:32 UTC 98a17f613c6b0172922f272553ea5b3ffcca00a011408d264a60d2fc3f894b64:26
|
Funding @ 2017-01-29 07:45:33 UTC 7b1484d4bc72c23869d3fc7e51aea1806e9b8bd15d596ca425b811b34c383ac4:7
Spending @ 2017-01-29 22:25:14 UTC 63fbdd7d12e816b5e761cc3f41ae88533fa13aa836bfa92a1383a1ef83dc55b8:1
|
Funding @ 2017-01-09 19:19:46 UTC fe85d85e59110f90a6183afb1f7051876ff4950bbfb89939a993eb3502b120e0:6
Spending @ 2017-01-10 10:29:51 UTC d4a9e970382ec325aa6b16cba57c2e4c1e3062534a2b985d921b9b71b6ce5fda:4
|
